Wegovy pill, the first FDA‑approved oral GLP‑1 for weight loss, is now available via WeightWatchers Med+ from $149 per month ...

Novo Nordisk released new data that could help boost the case for the higher dose version of its blockbuster obesity ...

A paediatrican who treats obese teens expects funding to come swiftly for weight loss drug Wegovy. Pharmac has added the drug ...

Pharmac has added the weight-loss drug Wegovy to its list of medicines suitable for future funding. In a decision released ...

This data could help support Novo in its bid to claw back market share taken by Eli Lilly in the obesity space.

The company said the majority of the weight loss—around 84%—came from losing body fat while preserving muscle function and ...

Novo Nordisk has identified a group of early responders to its high-dose Wegovy formulation that shed almost 28% of their ...

These drugs fall into a class known as GLP-1s, mimicking a natural hormone that helps regulate blood sugar, slows how quickly ...

A nationwide study from Denmark presented at the European Congress on Obesity (ECO2026) in Istanbul, Turkey, shows that use ...

Patients can receive the treatments at home for 'no additional cost' and will have the option of chatting with a pharmacist ...

For a limited time, patients can get a steep discount on the popular medications, as long as they’re paying out of pocket Steve Christo/Corbis/Corbis/Getty Ozempic ...